论文部分内容阅读
目的:观察健脾益肾生髓方对白血病化疗后白细胞减少症的疗效及其对血清超氧化物歧化酶(superoxide dismutase,SOD)、脂质过氧化物(LPO)的影响。方法:将52例白血病化疗后白细胞减少症患者随机分为治疗组和对照组各26例。对照组采用常规治疗,治疗组在对照组基础上予健脾益肾生髓方口服。观察比较两组生活质量改善情况、白细胞计数、SOD、LPO水平。结果:治疗后两组患者血清SOD均不同程度升高(P<0.05),且治疗后治疗组血清SOD高于对照组(P<0.05);两组患者治疗后血清LPO含量均降低(P<0.05),但治疗后两组比较,差异无统计学意义(P>0.05)。治疗组临床疗效优于对照组,差异有统计学意义(P<0.05)。治疗组感染率低于对照组,差异有统计学意义(P<0.05)。治疗组生活质量改善情况优于对照组,差异有统计学意义(P<0.05)。结论:健脾益肾生髓方干预白血病化疗后白细胞减少症有较好疗效,可调节患者血清SOD、LPO水平,改善患者生活质量。
Objective: To observe the therapeutic effect of Jianpi Yishen Shengsui Fang on leucopenia after chemotherapy and its effect on serum superoxide dismutase (SOD) and lipid peroxides (LPO). Methods: Fifty-two patients with leukemia after chemotherapy of leukemia were randomly divided into treatment group and control group, with 26 cases in each group. The control group with conventional treatment, the treatment group on the basis of the control group to spleen Yisheng Sheng marrow prescription. The quality of life improvement, white blood cell count, SOD and LPO levels were observed and compared between the two groups. Results: After treatment, serum SOD in both groups increased to some extent (P <0.05), and the serum SOD in the treatment group after treatment was higher than that in the control group (P <0.05). The serum LPO levels in both groups decreased after treatment (P < 0.05), but there was no significant difference between the two groups after treatment (P> 0.05). The clinical efficacy of the treatment group was better than that of the control group, the difference was statistically significant (P <0.05). The treatment group infection rate was lower than the control group, the difference was statistically significant (P <0.05). The improvement of quality of life in the treatment group was better than that in the control group, the difference was statistically significant (P <0.05). Conclusion: Spleen Yishen Shengsuo Fang intervention leukemia after chemotherapy leukopenia has a good effect, can regulate serum SOD, LPO levels and improve the quality of life of patients.